ABVD

ABVD is a chemotherapy regimen used in the first-line treatment of Hodgkin lymphoma, replacing the older MOPP protocol. It consists of concurrent treatment with the chemotherapy drugs:

• Adriamycin (also known as doxorubicin/hydroxydaunorubicin, designated as H in CHOP)
• Bleomycin
• Vinblastine
• Dacarbazine (similar to procarbazine, designated as P in MOPP and in COPP)